Jardiance (empagliflozin) is a widely used oral medication for the treatment of type 2 diabetes, with additional benefits for heart and kidney health. It belongs to the class of SGLT2 inhibitors, which act directly on the kidneys to regulate blood glucose levels.
This mechanism makes it different from many traditional diabetes treatments that primarily target insulin pathways.
What Jardiance Is Used For
Jardiance is prescribed for:
- Type 2 diabetes management
- Heart failure support
- Kidney protection
For a full overview of dosage, benefits, and usage, see this guide on how Jardiance (empagliflozin) tablets are used in treatment:
jardiance empagliflozin tablets detailed guide
Mechanism of Action
Jardiance works by inhibiting the sodium-glucose co-transporter 2 (SGLT2) in the kidneys. This leads to:
- Increased glucose excretion through urine
- Lower blood sugar levels
- Reduced strain on the cardiovascular system
Dosage and Administration
Typical dosing includes:
- Starting dose: 10 mg once daily
- Taken with or without food
- Used consistently at the same time each day
Additional Health Benefits
Jardiance may also:
- Support heart health
- Help reduce cardiovascular risk
- Slow progression of kidney disease
Side Effects
Possible side effects include:
- Increased urination
- Urinary tract infections
- Mild dehydration
Clinical Information
For medically reviewed details on how empagliflozin works, see this clinical overview of empagliflozin mechanism and safety:
empagliflozin mechanism and safety overview
Conclusion
Jardiance is a modern therapy that not only lowers blood sugar but also provides important cardiovascular and kidney benefits. With proper use, it can significantly improve long-term outcomes in patients with type 2 diabetes.
